Latest filing published 09 Aug 2022 for Lexicon Pharmaceuticals, INC., €360k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -38.1%Entry US$2.78 · Close at T+365 US$1.72
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Invus US Partners LLC: trading record in brief
This profile gathers the share dealings of Invus US Partners LLC in Lexicon Pharmaceuticals, Inc. Over a trading history stretching from 1 August 2022 to 5 August 2022, the count stands at 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €2.8M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 9 August 2022, reports an open-market purchase of €360k in Lexicon Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Invus US Partners LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 147,390 shares@ US$2.5013.1% of flowCommon StockSEC:0000899243-22-028113:0Canonical exit: 3 Nov 2022 (T+90)
- 982,600 shares@ US$2.5086.9% of flowCommon StockSEC:0000899243-22-027157:0Canonical exit: 30 Oct 2022 (T+90)
2 of 1 declaration